(Q37903852)

25 August 2017

1 reference

title

Regulatory T cells in gastrointestinal tumors (English)

1 reference

25 August 2017

Sukanya Raghavan

1

1 reference

25 August 2017

Marianne Quiding-Järbrink

series ordinal

2

1 reference

25 August 2017

publication date

1 August 2011

1 reference

Expert Review of Gastroenterology & Hepatology

25 August 2017

published in

1 reference

25 August 2017

volume

5

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

489-501

1 reference

Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

25 August 2017

cites work

1 reference

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

21 January 2018

1 reference

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

21 January 2018

1 reference

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

21 January 2018

1 reference

Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens

21 January 2018

1 reference

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

21 January 2018

1 reference

Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.

21 January 2018

1 reference

Role of endogenous and induced regulatory T cells during infections

21 January 2018

1 reference

Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion

21 January 2018

1 reference

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

Developmental regulation of Foxp3 expression during ontogeny.

21 January 2018

1 reference

Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes

21 January 2018

1 reference

Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells

21 January 2018

1 reference

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

21 January 2018

1 reference

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

Transforming growth factor-beta: recent progress and new challenges

21 January 2018

1 reference

Transient regulatory T-cells: a state attained by all activated human T-cells.

21 January 2018

1 reference

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function

21 January 2018

1 reference

Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.

21 January 2018

1 reference

Inflammation, atrophy, and gastric cancer

21 January 2018

1 reference

Risk of cancer in ulcerative colitis

21 January 2018

1 reference

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

21 January 2018

1 reference

Macrophage polarization in tumour progression

21 January 2018

1 reference

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

21 January 2018

1 reference

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

21 January 2018

1 reference

Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma

21 January 2018

1 reference

Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer

21 January 2018

1 reference

Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner

21 January 2018

1 reference

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

21 January 2018

1 reference

Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data

21 January 2018

1 reference

Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

21 January 2018

1 reference

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

21 January 2018

1 reference

High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

21 January 2018

1 reference

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

21 January 2018

1 reference

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis

21 January 2018

1 reference

Wnt signalling in the mouse intestine

21 January 2018

1 reference

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

21 January 2018

1 reference

Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.

21 January 2018

1 reference

Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa

21 January 2018

1 reference

21 January 2018

1 reference

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors

21 January 2018

1 reference

Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells

21 January 2018

1 reference

TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes

21 January 2018

1 reference

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

T-cell recruitment to the intestinal mucosa

21 January 2018

1 reference

Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress.

21 January 2018

1 reference

Lymphocyte homing and homeostasis

21 January 2018

1 reference

Chemokines in tissue-specific and microenvironment-specific lymphocyte homing

21 January 2018

1 reference

Regulatory T-cell compartmentalization and trafficking

21 January 2018

1 reference

CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential

21 January 2018

1 reference

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

Mini-review: overcoming tumor-intrinsic resistance to immune effector function.

21 January 2018

1 reference

Transformation of the microvascular system during multistage tumorigenesis

21 January 2018

1 reference

Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation

21 January 2018

1 reference

Mechanisms of foxp3+ T regulatory cell-mediated suppression

21 January 2018

1 reference

Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response

21 January 2018

1 reference

Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes

21 January 2018

1 reference

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

21 January 2018

1 reference

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer

21 January 2018

1 reference

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

21 January 2018

1 reference

Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis

21 January 2018

1 reference

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction

21 January 2018

1 reference

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

IL-35-mediated induction of a potent regulatory T cell population.

21 January 2018

1 reference

Interleukin-35: odd one out or part of the family?

21 January 2018

1 reference

CD4+ CD25high regulatory T cells reduce T cell transendothelial migration in cancer patients

21 January 2018

1 reference

Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.

21 January 2018

1 reference

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

21 January 2018

1 reference

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels

21 January 2018

1 reference

A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice

21 January 2018

1 reference

Successful colon cancer eradication after chemoimmunotherapy is associated with profound phenotypic change of intratumoral myeloid cells.

21 January 2018

1 reference

CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy

21 January 2018

1 reference

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

21 January 2018

1 reference

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

21 January 2018

1 reference

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

21 January 2018

1 reference

Ipilimumab: controversies in its development, utility and autoimmune adverse events

21 January 2018

1 reference

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.

21 January 2018

1 reference

Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer

21 January 2018

1 reference

Pilot study of sentinel-node-based adoptive immunotherapy in advanced colorectal cancer

21 January 2018

1 reference

Therapeutic cancer vaccines: are we there yet?

21 January 2018

1 reference

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer

21 January 2018

1 reference

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes

21 January 2018

1 reference

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

21 January 2018

1 reference

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.44

1 reference

25 August 2017

1 reference